1. Introduction {#sec1}
===============

Compelling evidence indicates that females are more susceptible to anxiety than males ([@bib47], [@bib59], [@bib62]), mainly in phases of the hormonal cycle when serum levels of estrogen are low, such as during premenstrual and peri-menopausal periods, or after bilateral oophorectomy ([@bib1], [@bib15], [@bib57], [@bib70], [@bib72]). During these periods, there appears to be an increase in sensitivity to stressors ([@bib8], [@bib41], [@bib66]). Experimental and clinical studies (in mice, rats, and humans) have demonstrated that estrogen replacement treatment minimizes the effect of stressors, decreases anxiety ([@bib79], [@bib80], [@bib81]), and affects the functionality of the serotonergic system ([@bib3], [@bib19], [@bib33], [@bib46], [@bib56]).

The median raphe nucleus (MRN) is considered to be a crucial source of serotonergic neurons that project to prosencephalic structures related to stress and anxiety, such as the dorsal hippocampus ([@bib12], [@bib58]). These anatomic analyses support theoretical assumptions that the MRN-dorsal hippocampus pathway is a critical component in stress resistance ([@bib22]) and in anxiogenesis ([@bib4]) by integrating Gray\'s "behavioral inhibition system" ([@bib35]).

Several studies have demonstrated the effects of stimulation or inactivation of the MRN on anxiety (for review see [@bib4]). More specifically, serotonergic neurons from the MRN were involved in the manifestation of freezing in contextual conditioning ([@bib6], [@bib9], [@bib10], [@bib29], [@bib51], [@bib73], [@bib74]), an anxiety test which involves aversive conditioning and spatial context ([@bib27], [@bib65]). In addition, there is a wealth of experimental evidence indicating that the dorsal hippocampus, the main projection of the MRN, facilitates learning contextual characteristics in which conditioning occurred ([@bib27], [@bib34], [@bib36], [@bib53], [@bib54]).

Estrogen receptors have been identified in neurons located in the MRN ([@bib48], [@bib2]), indicating a role for estrogen in this location. It is possible this role is to potentiate the action of serotonin on somatodendritic 5-HT~1A~ receptors, inhibiting the function of serotonergic neurons ([@bib56], [@bib39]), and causing anxiolysis ([@bib6], [@bib5]). One study showed that the microinjection of estradiol benzoate (EB: β-estradiol 3 benzoate) into the MRN of ovariectomized rats decreased the manifestation of freezing in the same context as that in which the animals received foot shocks ([@bib5]). This effect was reversed by prior injection of WAY100.635, a 5-HT~1A~ receptor antagonist. In this case, the pharmacological manipulations were conducted 24 h after the aversive conditioning session, immediately before exposure to the context (test session). Thus, EB blocked the association between the aversive experience and the context.

The present study aimed to evaluate whether the estradiol microinjected into the MRN before exposure to an aversive stimulus (foot shocks) would impair the acquisition of aversive information and the association with context, and if the 5-HT~1A~ receptors would be involved in this effect. The hypothesis of this investigation was that estradiol could contribute for the decrease of the aversive conditioning process, minimizing anxiety-like behavior in ovariectomized rats by modulating the function of the serotonergic neurons in MRN.

2. Materials and methods {#sec2}
========================

2.1. Animals {#sec2.1}
------------

Normal cycling female *Wistar* rats, weighing 200 g and that were at least 2 months old, were housed, five animals in one polypropylene cage (41 × 34 × 17 cm) with wood shavings on the floor, for 7 days until ovariectomy. After stereotaxic surgery, the animals were housed in pairs. The rats were maintained on a 12 h light-dark cycle (7:00--19:00, 50 lux) in a temperature-controlled room (21 ± 2 °C) and given free access to food and water throughout the experiment, except during testing. The animals were handled three times a week to clean the cages.

Procedures were approved by the research ethics committee of São Paulo State University (Process 553/2009; CEP 015/2009) and were conducted in conformity with the Brazilian Society of Neuroscience and Behavior Guidelines for Care and Use of Laboratory Animals, which are in compliance with international laws and policies. All efforts were made to minimize animal suffering.

2.2. Drugs {#sec2.2}
----------

Estradiol benzoate (β-estradiol 3-benzoate; Sigma, USA) was dissolved in sesame oil (Sigma, USA) (1200 ng). WAY100.635 (N-\[2-(4-\[2-Methoxyphenyl\]-1-piperazinyl)ethyl\]-N-2-pyridinylcyclohexanecarboxamide) Sigma, USA, a selective 5-HT~1A~ receptor antagonist, was dissolved in saline (100 ng). Control animals received the same volume of the respective vehicle (sesame oil or saline).

2.3. Surgeries {#sec2.3}
--------------

All females were bilaterally ovariectomized under tribromoethanol anesthesia (250 mg/kg, IP; Aldrich, USA). Fourteen days later, a 15 mm guide cannula was implanted into the brain of the animals at a 20° angle, with its tip remaining 1.5 mm above the injection site. This procedure was performed on rats fastened to a stereotaxic instrument (David-Kopf, USA) under the same anesthetic described above, with the addition of a local anesthetic of 2% xylocaine. The following coordinates from the atlas of [@bib69] were used: anteroposterior = −7.8 mm; lateral = +2.9 mm; depth = −7.5 mm, taking the bregma as reference. The cannula was fixed to the skull with acrylic resin and a stainless steel screw.

At the end of the surgery, all animals were injected (IM) with 0.2 ml of antibiotic preparation (benzylpenicillin and streptomycin; Pentabiotico Veterinário Pequeno Porte, Fort Dodge, Brazil) to prevent possible infections.

2.4. Microinjection of drugs into the median raphe nucleus {#sec2.4}
----------------------------------------------------------

Microinjection was performed using a micro-syringe (Hamilton, USA) connected to the needle using a polyethylene tube. The micro-syringe was driven by a motor pump (Fisher Scientific Company - USA). A 16.5 mm stainless steel needle (0.3 mm external diameter) was introduced through the guide cannula into the MRN and a volume of 0.2 μl of each solution was injected during a 1 min period. The needle was held in place for another minute to avoid reflux. The two microinjections were conducted at a 5 min interval. A representative position of the needle tip in the MRN can be see in [Fig. 1](#fig1){ref-type="fig"}.Fig. 1Diagrammatic representation of coronal sections through the rat brain (mm posterior to bregma) showing the location of injection sites into MRN ([@bib69]). The number of points in the figures is less than the total number of rats included in the analysis (n = 41) because of several overlaps (on the left side). Photomicrograph of typical injection site (indicated by arrow) in the MRN (on the right side).Fig. 1

The dose of EB used was chosen on the basis of previously reported results ([@bib6], [@bib5]). The animals were given either saline or WAY100.635 in the first microinjection. Five minutes later, the animals received a second microinjection of sesame oil or EB. The rats were divided into four groups: Group 1 -- Saline + Oil (n = 10); Group 2 -- Saline + EB (n = 11); Group 3 -- WAY 100.635 + Oil (n = 10); Group 4 -- WAY100.635 + EB (n = 10). The rats were tested for contextual conditioning immediately after the second microinjection ([Fig. 2](#fig2){ref-type="fig"}).Fig. 2Experimental design -- summary description of the procedures and experimental groups.Fig. 2

2.5. Contextual conditioning test {#sec2.5}
---------------------------------

Seven days after stereotaxic surgery, immediately after microinjections, the animals were submitted to aversive conditioning in a Skinner box (30 × 20 × 25 cm). The ceiling, side and back walls of the box were made of stainless steel and the front door of transparent Plexiglas. The grid floor of the chamber consisted of stainless steel rods 1.2 cm. Ten inescapable foot shocks (0.7 mA, 1 s, intertrial interval varied randomly between 20 and 50 s) were delivered through the cage floor by a constant current generator (Insight, Brazil). Contextual conditioning (the test session) was evaluated in the same box for 5 min, 24 h after the aversive conditioning session.

Several behavioral measures were recorded to assess the level of contextual conditioning: the frequency and duration of freezing, rearing and grooming behaviors; the frequency of locomotion; and the number of fecal boluses and bouts of micturition. Freezing was operationally defined as the total absence of movement of the body and vibrissae for a minimal period of 6 s, accompanied by at least two of the following responses: arched back, retraction of the ears, piloerection or exophthalmos. Rearing and grooming were defined respectively as standing with raised forelegs placed either in the air or against the walls of the cage and as licking the fur, beginning by the muzzle, going to the ears and down to the rest of the body ([@bib9], [@bib10]).

Both the training and test sessions were conducted between 14:00--17:00 h. The brightness level in the conditioning box was 50 lux. Before positioning the next rat, the apparatus was cleaned with 20% ethanol. The experimenter remained outside the room, and the behavior of the rat was recorded on videotape, which was later analyzed using the standardized software Etholog 2.25, by an investigator blinded to the treatment group of the animal ([@bib67]).

2.6. Identification of microinjection sites {#sec2.6}
-------------------------------------------

Immediately after behavioral assessment, the animals were anesthetized with a lethal dose of sodium pentobarbital (IP). The brain was perfused intracardially with 0.9% saline solution followed by 10% formalin solution before being removed and fixed in a 10% formalin solution at a temperature of 0--4 °C for 3 days, for subsequent evaluation of microinjection sites by histological analysis. Brain slices of 50 μm were cut by means of a microtome and stained with cresyl violet acetate (Sigma) (Nissl staining). The injection sites were determined using diagrams of the atlas by [@bib69]. Ten animals were excluded from data analysis due to placement of the cannula outside the MRN. Forty-one rats with microinjection sites precisely located within the MRN were included in the study.

2.7. Data analysis {#sec2.7}
------------------

Results were analyzed by repeated measures analysis of variance (ANOVA two way): the behaviors presented in the aversive conditioning and test sessions (repeated measures) were compared, in addition to the treatments applied (pretreatment: first microinjection with saline or WAY100.635; and treatment - second microinjection with oil or EB). *Post-hoc* comparisons were made using LSD test (the Fisher Least Significant Difference Test) comparing four experimental groups: group 1 -- saline + oil; group 2 -- saline + EB; group 3 -- WAY100.635 + oil; group 4 -- WAY100.635 + EB; in each session (conditioning or test). Significant values were established at *p* \< 0.05.

3. Results {#sec3}
==========

The frequency of freezing behavior did not differ between the conditioning and test sessions ([Fig. 3](#fig3){ref-type="fig"} -- on top) \[*F*(1,37) = 0.00; *p* = 0.953\]. However, it was affected by pretreatment (saline or WAY100.635) \[*F*(1,37) = 11.73; *p* = 0.001\], but not by treatment (oil or EB) \[*F*(1,37) = 3.62; *p* = 0.065\]. There was an interaction between pretreatment and treatment \[*F*(1,37) = 5.81; *p* = 0.021\]. In the test session, females of the saline + EB group froze less often compared to the saline + oil group (*p* = 0.002), WAY100.635 + oil group (*p* = 0.001) and WAY00.635 + EB group (*p* = 0.004).Fig. 3Frequency and duration (seconds) of freezing (Mean + S.E.M.) during conditioning and test sessions, by ovariectomized rats submitted to microinjections into the MRN prior to aversive conditioning. N = 10--11. Columns represent means and bars represent S.E.M. ANOVA followed by LSD *post-hoc* test: ^++^*p* \< 0.01, represent differences between conditioning and test sessions within groups; \**p* \< 0.05; \*\**p* \< 0.01; \*\*\**p* \< 0.001 represent differences in relation to the Saline + EB group in the test session.Fig. 3

In contrast, the duration of freezing behavior ([Fig. 3](#fig3){ref-type="fig"} - bottom) differed between the conditioning and test sessions \[*F*(1,37) = 6.96; *p* = 0.012\]. The duration of freezing was higher in the test session in saline + oil and WAY100.635 + oil groups (p \< 0.01). Moreover, pretreatment (saline or WAY100.635) \[*F*(1,37) = 1.61; *p* = 0.213\] did not affect freezing duration, whereas treatment did (oil or EB) \[*F*(1,37) = 8.69; *p* = 0.005\], and there was an interaction between pretreatment and treatment effect \[*F*(1,37) = 6.06; *p* = 0.019\]. In the test session, rats that received saline + EB exhibited shorter duration of freezing than rats that received saline + oil (*p* \< 0.001), WAY100.635 + oil (*p* \< 0.001) or WAY100.635 + EB (*p* = 0.025).

The number of rearing behaviors -- vertical exploratory locomotor activity -- differed between the conditioning and test sessions ([Fig. 4](#fig4){ref-type="fig"} -- on top) \[*F*(1,37) = 32.73; *p* \< 0.001\]. However, neither pretreatment (saline or WAY100.635) \[*F*(1,37) = 0.09; *p* = 0.765\] nor treatment (oil or EB) \[*F*(1,37) = 0.47; *p* = 0.496\] affected the number of rearing behaviors. There was an interaction between the pretreatment and treatment effects \[*F*(1,37) = 10.05; *p* = 0.003\]: during the test session, females that received saline + EB reared more often than those that received saline + oil (*p* = 0.003), WAY100.635 + oil (*p* = 0.010) or WAY100.635 + EB (*p* = 0.018).Fig. 4Frequency and duration (seconds) of rearing (Mean + S.E.M.) during conditioning and test sessions, by ovariectomized rats submitted to microinjections into the MRN prior to aversive conditioning. N = 10--11. Columns represent means and bars represent S.E.M. ANOVA followed by LSD *post-hoc* test: ^+^*p* \< 0.05; ^++^*p* \< 0.01; ^+++^*p* \< 0.001 represent differences between conditioning and test sessions within groups; \**p* \< 0.05; \*\**p* \< 0.01 represent differences in relation to the Saline + EB group in the test session.Fig. 4

Similarly, the duration of rearing behavior ([Fig. 4](#fig4){ref-type="fig"} -- bottom) differed between conditioning and test sessions \[*F*(1,37) = 11.42; *p* = 0.002\]. There was no effect of pretreatment (saline or WAY100.635) \[*F*(1,37) = 4,01; *p* = 0.052\], or treatment (oil or EB) \[*F*(1,37) = 4.04; *p* = 0.052\], but there was an interaction between pretreatment and treatment effects \[*F*(1,37) = 7.71; *p* = 0.009\]. During the test session, rats that received saline + EB reared for longer time than rats that received saline + oil (*p* = 0.007), WAY100.635 + oil (*p* = 0.010) or WAY100.635 + EB (*p* = 0.022).

The number of locomotion in the Skinner box (horizontal exploratory locomotor activity; [Table 1](#tbl1){ref-type="table"}) differed between the conditioning and test sessions \[*F*(1,37) = 58.31; *p* \< 0.001\]. However, there was no effect of pretreatment (saline or WAY100.635) \[*F*(1,37) = 1.23; *p* = 0.275\], treatment (oil or EB) \[*F*(1,37) = 0.16; *p* = 0.687\], or interaction between pretreatment and treatment \[*F*(1,37) = 3.29; *p* = 0.078\].Table 1Number of locomotion and autonomic responses (Faecal boluses and micturition) shown by ovariectomized rats in the conditioning and test session, submitted to microinjections into the MRN of the Saline + Oil, Saline + EB, WAY 100.635 + Oil or WAY 100.635 + EB previously to aversive conditioning session.Table 1Contextual conditioning testGroupsLocomotionFaecal bolusesMicturitionConditioning SessionSaline + Oil17.80 ± 2.236.70 ± 1.271.40 ± 0.75Saline + EB18.73 ± 1.473.45 ± 0.921.27 ± 0.60Way + Oil23.70 ± 1.526.90 ± 0.852.10 ± 0.75Way + EB20.30 ± 2.036.80 ± 0.811.60 ± 0.62Test SessionSaline + Oil10.50 ± 1.56\
+++3.10 ± 0.96\
++1.10 ± 0.67Saline + EB15.73 ± 1.542.73 ± 0.910.64 ± 0.24Way + Oil12.70 ± 1.61\
+++3.60 ± 0.86\
++0.50 ± 0.22 +Way + EB12.20 ± 1.40\
+++2.70 ± 0.76\
++0.60 ± 0.22[^1]

Similarly, the number of grooming events differed between sessions ([Fig. 5](#fig5){ref-type="fig"} - on top) \[*F*(1,37) = 29.08; *p* \< 0.001\]. However, there was no effect of pretreatment (saline or WAY100.635) \[*F*(1,37) = 0.52; *p* = 0.476\], treatment (oil or EB) \[*F*(1,37) = 0.03; *p* = 0.854\], or interaction between pretreatment and treatment \[*F*(1,37) = 0.89; *p* = 0.350\]. Analysis of the duration of grooming showed similar results: there was a significant effect of session \[*F*(1,37) = 37.36; *p* \< 0.001; \], but there was no effect of pretreatment (saline or WAY100.635) \[*F*(1,37) = 0.26; *p* = 0.615\], treatment (oil or EB) \[*F*(1,37) = 0.30; *p* = 0.583\], or interaction between pretreatment and treatment \[*F*(1,37) = 0.03; *p* = 0.873\] ([Fig. 5](#fig5){ref-type="fig"} - bottom).Fig. 5Frequency and duration (seconds) of grooming (Mean + S.E.M.) during conditioning and test sessions, by ovariectomized rats submitted to microinjections into the MRN prior to aversive conditioning. N = 10--11. Columns represent means and bars represent S.E.M. ANOVA followed by LSD *post-hoc* test: ^++^*p* \< 0.01, ^+++^*p* \< 0.001 represent differences between conditioning and test sessions within groups.Fig. 5

The autonomic responses measured in this study -- the number of fecal boluses and bouts of micturition -- both differed between sessions \[fecal boluses: *F*(1,37) = 28.70; *p* \< 0.001\]; bouts of micturition: *F*(1,37) = 7.63; *p* \< 0.009\]. Even so, these autonomic variables were not affected by pretreatment or treatment (*p* \> 0.05) ([Table 1](#tbl1){ref-type="table"}).

4. Discussion {#sec4}
=============

In this work we investigated the hypothesis that estradiol in the MRN could contribute for the decrease of the aversive conditioning process, minimizing anxiety-like behavior in ovariectomized rats by modulating the function of the serotonergic neurons in MRN. For this, we used the Contextual Conditioning. This test is a form of Pavlovian conditioning where an unconditioned stimulus (foot shock -- acute aversive stimulus) becomes associated with the context in which the stimulus was given. This form of conditioning has been used to assess anxiety in animals that are subsequently placed in the same context in which they received the acute stressor stimulus. When returned to the context, animals perceived potential danger, which characterizes the state of anxiety. In this condition, animals commonly freeze, characterized as becoming immobile, which constitutes the main behavioral parameter associated with aversive context conditioning ([@bib27]). It has been reported that anxiolytics and antidepressants (acute treatment) can minimize the manifestation of this behavior in this test ([@bib20], [@bib61]).

In the present study, ovariectomized females treated with saline + oil into MRN (control animals) showed an increase in the expression of freezing and a decrease in locomotion and rearing, as well as decrease in the fecal boluses elimination in the test sessions, of the same context in which they were exposed to aversive conditioning with electric shocks. Ovariectomized females that received microinjection of the Way100635 + oil into MRN presented with the same behaviors. These results were expected, because the dose used was below threshold for inducing behavioral effects on its own, and this group served as a control group. These findings confirm similar results found in contextual conditioning test in male rats ([@bib9], [@bib10], [@bib11], [@bib21], [@bib28], [@bib60], [@bib71], [@bib73], [@bib74], [@bib77]) and in ovariectomized rats ([@bib5]). Previous studies also showed that the removal of contextual signals associated with shock, i.e. when rats were placed in a box in which foot shocks were not given, in a different location, the freezing was absent ([@bib9], [@bib10], [@bib11], [@bib27]).

A wealth of investigations has demonstrated involvement of the MRN in the manifestation of freezing during contextual conditioning ([@bib9], [@bib10], [@bib11], [@bib18], [@bib60], [@bib73], [@bib74]). It is already known that the MRN projects heavily to the septomedial and hippocampal regions, in which a large amount of serotonergic neurons participate ([@bib58]). In Gray\'s behavioral inhibition process ([@bib35]), the septo-hippocampal system has a pivotal role. In particular, the dorsal hippocampus, the main MRN projection, is involved in processing cognitive and spatial information. Therefore, this pathway would be recruited in aversive situations associated with a context, leading to behavioral inhibition. According to hypotheses proposed by [@bib22], this activation would occur as a result of conditioned and unconditioned chronic stimuli, promoting resilience to stress by strengthening "coping" ([@bib68]).

As the MRN receives afferents from regions related to perception or processing of aversive stimuli, such as the *locus coeruleus* and the hypothalamus (medial and lateral pre-optic areas, anterior and lateral hypothalamus, hypothalamic dorso-medial, and arcuate nuclei) ([@bib37], [@bib38], [@bib52]), serotonergic neurons in the MRN would be activated by stimulation of nor-adrenaline and/or CRH (Corticotropin Releasing Hormone) receptors in this region ([@bib32], [@bib64]). That is, the acute aversive stimuli, the exposure to electric shocks, would activate the MRN-dorsal hippocampus pathway, promoting the storage of spatial information, since the dorsal hippocampus exerts this function.

In addition, there are intra-raphe modulatory mechanisms dependent on the local GABAergic circuitry, which is characterized by interneurons that exert inhibition of ascending 5-HT transmission ([@bib50], [@bib76]) or of indolaminergic negative feedback ([@bib38]). There is a mutual local control through the bilateral interconnection of serotonergic neurons between the dorsal raphe nucleus (DRN) and the MRN ([@bib38]). Endogenous serotonin activates 5-HT~1A~ receptors located in the dendrites or the cell body of neurons, also called somatodendritic receptors, reducing neuronal firing and, consequently, the release of 5-HT in terminal area projections ([@bib37], [@bib45], [@bib63]). There is a higher density of 5-HT~1A~ receptors in MRN serotonergic neurons, unlike the DRN, where these receptors are also identified in non-serotonergic neurons ([@bib14], [@bib44]).

It is known that inactivation of MRN neurons by 5-HT~1A~ receptor agonists causes anxiolysis in different tests of anxiety, similar to anxiolysis that occurs as a result of lesions of this structure ([@bib4]). Microinjection of 8-OH-DPAT, a 5-HT~1A~ receptor agonist, in the MRN impairs the acquisition of contextual fear in male rats ([@bib9], [@bib10], [@bib11], [@bib18], [@bib60], [@bib73], [@bib74]). On the other hand, prior injections of a silent dose of WAY100.635, a 5-HT~1A~ receptor antagonist, into the MRN reversed the anxiolytic effect of 8-OH-DPAT in the elevated T-maze ([@bib25], [@bib26], [@bib78]) and in a dark-light transition test ([@bib78]).

These aspects strengthen the hypothesis that MRN serotonergic neurons are involved in anxiety in both innate situations as well as in conditioning experiments. However, the main focus of the present study was to understand female behavior, especially in females with loss of ovarian function (transitional or surgical post-menopause), in situations related to aversive conditioning. It is well established that ovariectomy increases the manifestation of freezing during contextual conditioning tests ([@bib36]) and that treatment with estradiol decreases it ([@bib13]). Similar effects are observed during proestrus, a period when the levels of sexual steroids (estradiol and progesterone) are elevated ([@bib30]), in some anxiety tests ([@bib31], [@bib55]). It should be emphasized that not all studies show variation with the estrous cycle in these various tests of anxiety ([@bib24] for review). These apparent discrepancies could be related to other factors, for example, the interaction between sexual hormones and glucocorticoids ([@bib75]).

In the present investigation the estradiol was microinjected into MRN of the ovariectomized rats before the conditioning session and the behavioral results (freezing and rearing) were reversed in the test session. This estradiol effect was antagonized by Way 100635. The other parameters evaluated, such as locomotion, grooming and faecal boluses were not affected by treatment with EB. The urinary elimination was not affected either by aversive conditioning or by EB treatment.

The behavioral effects of estradiol in the MRN may be due to a genomic action, a non-genomic action, or to both (for review see [@bib75]). We hypothesize that immediate, non-genomic mechanisms of EB affect the activity of serotonergic neurons: the rapid infusion of EB can hyperpolarize neurons in seconds, through the opening of K^+^ channels that inhibit neuronal activity. These immediate effects of EB on neuronal firing are likely due to the activation of non-genomic mechanisms modulating several neurotransmitters, including 5-HT ([@bib42], [@bib43]). The functions of estrogen in serotonergic activity are well-described ([@bib23]): it increases the activity of tryptophan hydroxylase (an enzyme involved in the synthesis of 5-HT), resulting in an increase in overall 5-HT availability; it increases 5-HT by decreasing expression of monoamine oxidases (the enzymes responsible for degradation of 5-HT); it regulates serotonergic tone by modulating expression of the serotonin reuptake transporter (SERT); it modulates serotonin neuronal firing by affecting the distribution and state of 5-HT receptors, specifically presynaptic 5-HT~1A~ autoreceptors and 5-HT~2A~ receptors ([@bib3], [@bib33]). In this same direction, [@bib49] showed that ovariectomy increased the binding of a 5-HT~1A~ agonist (\[3H\]8-OH-DPAT) in rat DRN neurons. Treatment with estradiol reversed this effect and restored the binding levels to those of intact animals.

In this investigation, it is possible that ovariectomy caused an increase in the expression of 5-HT~1A~ receptors in the MRN. As estradiol potentiates local 5-HT activity on 5-HT~1A~ receptors, the acute effect of EB in the MRN in ovariectomized rats may also have potentiated the inhibitory role of 5-HT~1A~ receptors on the activity of MRN serotonergic neurons. Therefore, if estradiol chronically desensitizes 5-HT~1A~ receptors ([@bib16]), the loss of estrogen, mainly in menopause (transitional and surgical), could cause an increase in 5-HT~1A~ receptors in the MRN ([@bib3], [@bib17]). However, in females at this life stage, there would likely be no endogenous estrogen to potentiate the activity of serotonin on 5-HT~1A~ somatodendritic receptors. Consequently, anxiogenesis could be promoted with acute aversive stimuli.

Our previous studies, based on the identification of estrogen receptors in cell bodies of neurons located in the MRN ([@bib2], [@bib48]), demonstrated that, in ovariectomized rats, the microinjection of EB into this structure, immediately before the behavioral evaluation, increased open arms exploration in the elevated plus-maze. The same procedure diminished the freezing manifestation (duration in seconds) in contextual conditioning in the test sessions. In addition, these anxiolytic-like effects were reversed by prior injection of WAY100.635 into the MRN ([@bib6], [@bib5]).

The results of the present research confirm previous results. However, in this study, the microinjection of EB into the MRN was performed before animals were exposed to the aversive event. This experimental procedure did not affect the behaviors of ovariectomized rats in the conditioning session, but prevented the freezing manifestation in the test session and increased the rearing presentation, 24 h after the aversive conditioning. A rapid non-genomic effect of EB on somatodendritic 5-HT~1A~ receptors in the MRN may have occurred. This action may have damaged the normal functioning of the MRN-dorsal hippocampus pathway, impeding the storage of aversive information (foot shocks) and association of this experience to context in other time.

Grooming, an innate behavior that can generally be increased in two situations, high or low levels of stress ([@bib40]), was only increased during the test session, similar to the response of male rats to restraint ([@bib7]), but was not modified by any treatment in the present study. The electrolytic lesion in the MRN diminished the presentation of grooming in an elevated plus-maze, but specific lesions with 5,7-DHT did not affect this behavior ([@bib7]). Taken together, these results suggest that grooming could be affected by the function of non-serotonergic neurons originating in the MRN.

5. Conclusion {#sec5}
=============

In conclusion, the microinjection of EB into the MRN, prior to the exposure of the animals to aversive stimulus (foot shocks), did not alter the behaviors of animals in the conditioning session (freezing and rearing), but neutralized the association of the aversive experience with the context. It is possible that the steroid EB damaged the acquisition of the aforementioned association, and therefore, affected behavioral responses, due to serotonergic activity blockage in the MRN, since this effect was reversed by previous microinjection of WAY100.635. Hence, EB may exert a function on serotonergic neurons originating in the MRN, minimizing the impact of acute aversive experience on behavior by impairing the storage of aversive information. Periods of low estrogen concentration could contribute to increased perception of aversive stimuli, promoting an increase in anxiety-like behavior in female rats. Making an analogy to human experience in a translational approach, anxiety in women is augmented in moments when there is a low concentration of estrogen, and potentiated in environments where aversive experiences happen, or when remembering the place where undesirable or aversive stimuli occurred ([@bib70], [@bib72]). The results may explain estradiol\'s mechanism of action in preventing these effects by acting as an inhibitor of the serotonergic pathway MRN\--Dorsal Hippocampus and so attenuating the association of the aversive experience to the context.

This work was supported by grant \# 2010/06414-3 from São Paulo Research Foundation (FAPESP).

[^1]: Mean ± S.E.M. N = 10--11. LSD test after ANOVA: ^+^\<0.05; ^++^*p* \< 0.01; ^+++^*p* \< 0.001, represent differences between conditioning and test session in the same group.
